Neuralink, the brainchild of tech mogul Elon Musk, has been given the green light by the Food and Drug Administration to proceed with implanting a brain chip in a second human test subject. Despite facing issues in its initial trial with quadriplegic Noland Arbaugh, Neuralink has proposed a fix for the problems encountered during the first implantation. The company plans to address the issue of wires coming loose by inserting them deeper into the next subject’s brain – a procedure that may sound a tad gruesome, particularly given the controversial history of the company involving a monkey death toll.
The challenges faced by Neuralink’s first test subject, Arbaugh, have been emotionally taxing, with the loss of functionality in the implanted chip proving to be a rollercoaster of experiences for him. While the initial high of restored abilities such as improved communication and mind-controlled gaming was exhilarating, the subsequent loss of these functions hit Arbaugh hard. His account of the threads being pulled out from his brain paints a vivid picture of the struggles faced by those involved in such groundbreaking medical experiments.
Despite the setbacks, Neuralink has not been deterred and has implemented algorithmic solutions to make the most of the remaining threads in Arbaugh’s implant. With only 15 percent of the wires still intact and transmitting data, the company is determined to move forward with its ambitious plans. The FDA’s approval paves the way for Neuralink to select a candidate from the pool of over 1,000 applicants for the next implantation, scheduled for June as per insider reports.
While the journey has been far from smooth, it is evident that Neuralink is embracing the ethos of Silicon Valley, epitomized by the motto “Move fast and break things.” This philosophy, often associated with Musk’s rival Mark Zuckerberg, underscores the company’s willingness to take risks and push boundaries in the realm of neurotechnology. As Neuralink forges ahead with its pioneering work, the hope remains that the second implantation will build upon the lessons learned from past challenges, offering new possibilities for individuals like Arbaugh seeking to enhance their quality of life through cutting-edge advancements in medical science.
In the fast-paced world of tech innovation, Neuralink stands at the forefront of a revolution that has the potential to transform the way we interact with technology and harness the power of the human mind. As the company navigates the complexities of human trials and regulatory approvals, its unwavering commitment to pushing the boundaries of what is possible serves as a testament to the spirit of exploration and innovation that drives the pioneers of the modern age.
By
